Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes
FULL MENU

In silico method

In silico method

BACK

In silico method

In silico methods, or using computer modelling and simulation (CM&S), is utilised to amplify and accelerate the design, development, testing and regulatory approval of new medical treatments.

IMAGE GALLERY:

NEWS

News Welcome on Board, Hemolens Diagnostics!

Welcome on Board, Hemolens Diagnostics!

We are delighted to welcome Hemolens Diagnostics as a new member of the Avicenna Alliance!

News Poll on Computer Modelling & Simulation

Poll on Computer Modelling & Simulation

The Avicenna Clinical Deployment Task Force, led by Co-Chairs Erica Beaucage-Gauvreau & René Bombien, is engaged to grow a network of professionals with expertise in clinical applications of in silico methodologies, to foster collaboration and knowledge exchange.

News April 8th - Avicenna Webinar on ERAMET: Advancing Orphan & Paediatric Drug Development

April 8th - Avicenna Webinar on ERAMET: Advancing Orphan & Paediatric Drug Development

Join Next Avicenna Webinar on ERAMET: Advancing Orphan & Paediatric Drug Development! The EU-funded ERAMET project is transforming how orphan and paediatric medicines are developed. By integrating advanced Computational Modelling & Simulation (CM&S) techniques with real-world data, ERAMET is building a transparent ecosystem to support both medicine developers and regulators.

Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2025 Avicenna Alliance | powered by We Berry